Risk Factors for Quinolone Resistance Among ESBL Producing Klebsiella Species



Status:Completed
Conditions:Infectious Disease
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:18 - Any
Updated:6/16/2018
Start Date:August 2007
End Date:December 2017

Use our guide to learn which trials are right for you!

Risk Factors for Quinolone Resistance Among Extended-Spectrum Beta-Lactamase-Producing Klebsiella Species

This is a retrospective chart review. This proposed study aims to document the risk factors
for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally, the
adequacy of empiric antibiotic therapy for Klebsiella bloodstream infections will be
assessed.

This is a retrospective chart review. This proposed study aims to document the risk factors
for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally, the
adequacy of empiric antibiotic therapy for Klebsiella bloodstream infections will be
assessed. This research is (c) important because identification of risk factors may allow
earlier initiation of appropriate therapy in patients infected with these bacteria.
Additionally, we will identify whether horizontal spread is responsible for this increasing
trend.

Inclusion Criteria:

- must be quinolone resistant among ESBL producing klebsiella species

Exclusion Criteria:

- Those not meeting entry criteria
We found this trial at
1
site
200 Lothrop St
Pittsburgh, Pennsylvania 15213
University of Pittsburgh Medical Center UPMC is one of the leading nonprofit health systems in...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials